Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK5852 (GSK2485852) is an HCV NS5B RdRp polymerase inhibitor. GSK5852 inhibits NS5B (IC50: 50 nM). GSK5852 exhibits antiviral effects against hepatitis C virus (HCV) with EC50 values of 3.0 nM for GT1a and 1.7 nM for GT1b.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | GSK5852 (GSK2485852) is an HCV NS5B RdRp polymerase inhibitor. GSK5852 inhibits NS5B (IC50: 50 nM). GSK5852 exhibits antiviral effects against hepatitis C virus (HCV) with EC50 values of 3.0 nM for GT1a and 1.7 nM for GT1b. |
Molecular Weight | 556.39 |
Formula | C27H27BF2N2O6S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.